Robert S. Schehr

483 total citations
8 papers, 391 citations indexed

About

Robert S. Schehr is a scholar working on Cognitive Neuroscience, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Robert S. Schehr has authored 8 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cognitive Neuroscience, 2 papers in Pharmacology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Robert S. Schehr's work include Memory and Neural Mechanisms (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Alzheimer's disease research and treatments (2 papers). Robert S. Schehr is often cited by papers focused on Memory and Neural Mechanisms (3 papers), Neuroscience and Neuropharmacology Research (2 papers) and Alzheimer's disease research and treatments (2 papers). Robert S. Schehr collaborates with scholars based in United States, Sweden and Czechia. Robert S. Schehr's co-authors include Markus Kessler, Richard Granger, José Ambros‐Ingerson, Gary Lynch, Gary A. Rogers, Gary Lynch, Martin Ingvar, Mike Davis, G A Rogers and Cyrus Levinthal and has published in prestigious journals such as Nature Biotechnology, Experimental Neurology and International Clinical Psychopharmacology.

In The Last Decade

Robert S. Schehr

8 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert S. Schehr United States	5	272	190	113	66	55	8	391
Nicolas Aznavour Canada	14	321 1.2×	198 1.0×	106 0.9×	93 1.4×	78 1.4×	14	481
K Kolasa United States	12	281 1.0×	212 1.1×	78 0.7×	61 0.9×	62 1.1×	35	399
Danielle Cécyre Canada	8	227 0.8×	273 1.4×	77 0.7×	104 1.6×	55 1.0×	12	457
Peter Baumann Switzerland	13	499 1.8×	368 1.9×	76 0.7×	58 0.9×	87 1.6×	21	729
M.F. Pozza Switzerland	11	479 1.8×	262 1.4×	177 1.6×	55 0.8×	83 1.5×	12	594
Valérie Fauchey France	6	253 0.9×	135 0.7×	73 0.6×	71 1.1×	42 0.8×	6	369
Mohammad-Reza Zarrindast Iran	11	220 0.8×	192 1.0×	92 0.8×	35 0.5×	56 1.0×	18	441
T.M. Ballard Switzerland	9	343 1.3×	214 1.1×	109 1.0×	28 0.4×	70 1.3×	12	458
J Mizoule	6	370 1.4×	177 0.9×	96 0.8×	37 0.6×	43 0.8×	10	543
Paulianda J. Jones United States	8	373 1.4×	333 1.8×	107 0.9×	45 0.7×	38 0.7×	8	493

Countries citing papers authored by Robert S. Schehr

Since Specialization

Citations

This map shows the geographic impact of Robert S. Schehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Schehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Schehr more than expected).

Fields of papers citing papers by Robert S. Schehr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Schehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Schehr. The network helps show where Robert S. Schehr may publish in the future.

Co-authorship network of co-authors of Robert S. Schehr

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Schehr. A scholar is included among the top collaborators of Robert S. Schehr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Schehr. Robert S. Schehr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Lynch, Gary, et al.. (1997). Evidence That a Positive Modulator of AMPA-Type Glutamate Receptors Improves Delayed Recall in Aged Humans. Experimental Neurology. 145(1). 89–92. 132 indexed citations

2.

Ingvar, Martin, José Ambros‐Ingerson, Mike Davis, et al.. (1997). Enhancement by an Ampakine of Memory Encoding in Humans. Experimental Neurology. 146(2). 553–559. 176 indexed citations

3.

Schehr, Robert S.. (1997). Amyloid hypothesis of Alzheimer's rides high—for now. Nature Biotechnology. 15(1). 19–20. 3 indexed citations

4.

Schehr, Robert S.. (1997). Rethinking the development of breast cancer. Nature Biotechnology. 15(6). 517–518. 2 indexed citations

5.

Lynch, Gary, Markus Kessler, G A Rogers, et al.. (1996). Psychological effects of a drug that facilitates brain AMPA receptors. International Clinical Psychopharmacology. 11(1). 13–20. 44 indexed citations

6.

Schehr, Robert S.. (1996). New treatments for acute stroke. Nature Biotechnology. 14(11). 1549–1554. 17 indexed citations

7.

Schehr, Robert S.. (1994). Therapeutic Approaches to Alzheimer's Disease. Nature Biotechnology. 12(2). 140–144. 16 indexed citations

8.

Levinthal, Cyrus & Robert S. Schehr. (1986). New Methods of Pattern Recognition for Three-Dimensional Reconstruction and Display of Nerves and Molecules. PubMed Central. 225–227. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact